Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BMRN

BioMarin

$75.55

-0.54 (-0.71%)

18:41
11/14/19
11/14
18:41
11/14/19
18:41
Hot Stocks
BioMarin CEO: Our products have a very long life cycle »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BMRN

BioMarin

$75.71

-0.385 (-0.51%)

14:17
11/14/19
11/14
14:17
11/14/19
14:17
Recommendations
BioMarin analyst commentary at Piper Jaffray »

Piper 'frustrated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BMRN

BioMarin

$75.55

-0.54 (-0.71%)

11:07
11/14/19
11/14
11:07
11/14/19
11:07
Hot Stocks
BioMarin sees GAAP break-even or better in 2020 assuming Valoctocogene launch »

BioMarin Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Tuesday
ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

, CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

STOK

Stoke Therapeutics

$30.87

1.04 (3.49%)

BMRN

BioMarin

$75.96

0.72 (0.96%)

BIIB

Biogen

$291.50

-2.41 (-0.82%)

AMGN

Amgen

$223.35

2.66 (1.21%)

CTVA

Corteva

$27.06

0.32 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

  • 09

    Dec

BMRN

BioMarin

$75.24

-0.67 (-0.88%)

07:43
11/12/19
11/12
07:43
11/12/19
07:43
Initiation
BioMarin initiated at SunTrust »

BioMarin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Over a week ago
BMRN

BioMarin

$74.29

2.06 (2.85%)

06:23
10/30/19
10/30
06:23
10/30/19
06:23
Recommendations
BioMarin analyst commentary at Citi »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BMRN

BioMarin

$71.21

1.73 (2.49%)

07:41
10/28/19
10/28
07:41
10/28/19
07:41
Recommendations
BioMarin analyst commentary at Canaccord »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BMRN

BioMarin

$69.48

0.41 (0.59%)

07:19
10/25/19
10/25
07:19
10/25/19
07:19
Recommendations
BioMarin analyst commentary at Wedbush »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BMRN

BioMarin

$69.07

1.34 (1.98%)

06:45
10/24/19
10/24
06:45
10/24/19
06:45
Recommendations
BioMarin analyst commentary at Nomura Instinet »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BMRN

BioMarin

$69.07

1.34 (1.98%)

06:20
10/24/19
10/24
06:20
10/24/19
06:20
Recommendations
BioMarin analyst commentary at Barclays »

BioMarin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.